The positive correlations were detected between the duration and tumor size (Kendall's correlation coefficient, r = 0.3, P < 0.0001), while no correlations were demonstrated between the duration of anti-HER2 targeted therapy and the additional variables (Figure 3). The gene discussed is ERBB2; the disease is neoplasm.